She discusses the definitions of multimorbidity, the vulnerabilities of older adults to medication issues, and the importance of regular medication reviews, with emphasis on appropriate prescribing and the role of healthcare professionals in supporting older adults in their medication management.

The conversation also covers specific medications like statins and aspirin, the management of hypertension, the risks associated with anticholinergic medications, and the need for equitable medication management for Māori and Pacific populations.

Suze highlights the significance of listening and validating the experiences of those grieving, while also addressing common misconceptions and traps that clinicians may fall into. The conversation explores various therapeutic approaches, cultural considerations, and the dual process model of grief, ultimately reinforcing the idea that grief is a normal human experience that requires compassionate support.

Helen will also discuss practical tools for assessing frailty, adverse outcomes, and effective management strategies.

Fibromyalgia is a collection of symptoms and is best termed a syndrome. The collection of symptoms includes widespread pain, poor sleep, fatigue, brain fog and sometimes depression. A sensitivity to light, sound, touch and smell is also described. There is generalised tenderness, which is how you diagnose the syndrome.

The New Zealand Carcinogens Survey reveals for the first time the extent to which New Zealanders experience cancer-causing substances and other exposures in their workplace. The survey, released in March this year, reports that more than half (58%) of all workers are exposed to at least one workplace carcinogen at some level.

ME/CFS is a poorly understood, yet relatively common medical condition, that can profoundly affect the lives of those who suffer from it. Sadly for decades myths have persisted around the aetiology and pathophysiology of ME/CFS, with many health providers historically even doubting its existence, and confusion still reigns when it comes to an evidence-based approach to management. So here to unpick some of the myths, and help us with an approach to assessing and supporting young people who develop ME/CFS are Dr Cathy Stephenson, a GP who has developed a special interest in the condition, and Rose Silvester, a mum of two teenage boys who are affected by it. We are also delighted to have special guest to give us insight.

Clozapine is a second generation or atypical antipsychotic prescribed for treatment-resistant schizophrenia. It is usually commenced by secondary mental health services. Clozapine is associated with several side-effects and patients require close monitoring.

GP’s are responsible for caring for these patients and this podcast provides guidance on management and monitoring.